Zongertinib could become a new tool in the treatment of HER-2 mutated lung cancer, specially for an specific group of patients
New oral drug shows high efficacy in HER2-mutated lung cancer Read More »
A type of autoantibodies is demonstrated to be an independent risk factor for the severity of COVID-19
New study on the causes of severe COVID-19 in vaccinated patients Read More »
Kleptomania is described for the first time not only as an impulsive disorder, but also as a compulsive disorder.
Kleptomania: Bellvitge leads a new approach in the study and treatment of the disease Read More »
The new tools are highly efficient, operate at colder temperatures, and appear to be more specific than the canonical system.
Dr. Roser Velasco, IDIBELL principal investigator at Neuro-Oncology group and neurologist at the Neuro-Oncology Unit of ICO Hospitalet and Bellvitge University Hospital, has co-directed the writing of an international guide of recommendations on the management of neurological complications associated with CAR-T cell therapy. Dr. Velasco has participated as an expert in neuro-oncology within the Committee
Megaloencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare childhood disease that mainly affects the white matter of the brain. Among other symptoms, it is characterized by macrocephaly, inability to coordinate motor movements, and epilepsy. More than 75% of diagnosed cases are due to mutations in the MLC1 gene, which encodes a protein located in
Gene therapy reverses the symptoms of a rare neurological disease in animal models Read More »
The significant increase in serious infections caused by S.dysgalactiae is confirmed, reaffirming the need to strengthen detection and surveillance systems
IDIBELL presented two talks on neuroscience research within the Pessics de Ciència cycle
The City Council will contribute €85.000 per year between 2025 and 2028.
Macrophages have a relevant role in intestinal regeneration
